Investor Relations


Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$9.35 + 0.25
Stock chart for: ZGNX.O.  Currently trading at $9.35 with a 52 week high of $16.56 and a 52 week low of $7.33.
Data as of 10/21/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent News More

Zogenix to Participate in Two Upcoming Investor Conferences

Read More

Zogenix to have Significant Presence at 12th European Congress on Epileptology

Read More

Investor Events More

Tuesday, September 27, 2016 4:00 p.m. ET
Zogenix, Inc. at Ladenburg Thalmann 2016 Healthcare Conference